Come and join us on 6 July and hear 4 AIM CEO’s speak. Brad George, Orosur CEO updates us on Colombia’s Tier-1 gold mine potential, Cliff Gross, CEO at Tekcapital explains how investors benefit from a special dividend. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8,415.00
Bid: 8,412.00
Ask: 8,414.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.02%)
Open: 8,337.00
High: 8,492.00
Low: 8,308.00
Yest. Close: 8,322.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

AstraZeneca weighs seeking full U.S. approval for COVID-19 shot -WSJ

Fri, 7th May 2021 22:52

May 7 (Reuters) - AstraZeneca Plc may skip asking
the U.S. Food and Drug Administration for emergency-use
authorization for its COVID-19 vaccine, and instead pursue the
more time-intensive application for a full-fledged license to
sell the shot, the Wall Street Journal reported on Friday.

Such a step would further delay any rollout of the British
drugmaker's shots in the United States, according to the report
https://on.wsj.com/3eWvrry, which cited people familiar with the
matter.
(Reporting by Kanishka Singh in Bengaluru
Editing by Chris Reese)

More News

Swiss health ministry data shows vaccinated people seldom hit by COVID-19

By John MillerZURICH, June 24 (Reuters) - Switzerland's move to allow large public events with 10,000-plus people from Saturday comes as government data appears to show vaccines are helping control new infections that are mostly hitting people who...

24 Jun 21 17:36

Oxford researchers say they developed blood test predictor of vaccine efficacy

By Ludwig BurgerFRANKFURT, June 24 (Reuters) - Researchers at Oxford University said on Thursday they have developed a method to predict the efficacy of new COVID-19 vaccines based on a blood test, potentially offering a short-cut around massive c...

24 Jun 21 16:01

UPDATE 2-FTSE 100 rises on dovish BoE; miners, pharma stocks lead gains

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* BoE maintains loose monetary policy* AstraZeneca, Anglo American top boosts to FTSE 100* Carnival falls after $2 billion quarterly loss* FT...

24 Jun 21 09:58

AstraZeneca, MSD prostate cancer drug gets China green light

(Sharecast News) - AstraZeneca and MSD's Lynparza prostate cancer drug has been granted conditional approval in China after a successful phase three trial, the companies said on Thursday.

24 Jun 21 07:34

Seychelles looking to diversity economy beyond tourism post-COVID - minister

By Omar MohammedNAIROBI, June 23 (Reuters) - Seychelles said on Wednesday it is looking to diversify its economy beyond its mainstay of tourism into areas such as fisheries after visitor numbers were battered by restrictions to arrest the spread o...

23 Jun 21 13:37

Wednesday broker round-up

(Sharecast News) - Hunting: JP Morgan upgrades overweight with a target price of 290p.

23 Jun 21 13:04

UPDATE 1-GSK pledges sales boost after split from consumer arm

(Adds details, background)June 23 (Reuters) - New GSK, the pharmaceuticals business being separated from its consumer health operations, pledged to increase sales by more than 5% a year to 2026, the group said on Wednesday, as it published details...

23 Jun 21 11:35

UPDATE 2-GSK's drugs arm to get $11 bln windfall from consumer spin-off

* GSK consumer arm to be demerged in middle of 2022* Drugs business to get 8 bln stg dividend from consumer arm* Lower debt ratio, dividend to boost finances of drugs arm (Adds CEO comment, detail, background)By Ludwig Burger and Pushkala AripakaJun...

23 Jun 21 11:35

UPDATE 3-GSK's drugs arm to get $11 bln booster from consumer spin-off

* GSK consumer arm to be demerged in middle of 2022* Drugs business to get 8 bln stg dividend from consumer arm* Lower debt ratio, dividend to boost finances of drugs arm (Adds details on dividend, debt, Pfizer comment, updates shares)By Ludwig Bur...

23 Jun 21 11:35

GSK sets out plans for listing of consumer products venture

June 23 (Reuters) - Britain's GSK on Wednesday unveiled a detailed plan to spin off its consumer healthcare venture with Pfizer into a separate company by the middle of next year, as the pharmaceutical giant sharpens its focus on prescription med...

23 Jun 21 11:10

Delta plus variant reclassified as 'variant of concern', experts sanguine for now

(Sharecast News) - India's Health Ministry has upgraded a new variant of Covid-19 dubbed Delta plus to a "variant of concern".

23 Jun 21 10:47

AstraZeneca's 'Orpathys' gets conditional approval in China

(Sharecast News) - AstraZeneca announced on Wednesday that 'Orpathys', or savolitinib, has been granted conditional approval in China to treat patients with non-small cell lung cancer (NSCLC), with MET exon 14 skipping alterations who have progressed following prior systemic therapy or were unable to receive chemotherapy.

23 Jun 21 07:33

Chile weighing issue of third booster dose of COVID-19 vaccine

By Fabian CamberoSANTIAGO, June 22 (Reuters) - Chile is studying the possibility of issuing a third, booster dose of COVID-19 vaccines, its president said on Tuesday, as the country seeks to beat back the latest wave of infections amid questions a...

22 Jun 21 20:25

IN BRIEF: Hutchmed lung cancer treatment savolitinib approved in China

IN BRIEF: Hutchmed lung cancer treatment savolitinib approved in China

22 Jun 21 20:16

UPDATE 2-AstraZeneca, Pfizer vaccines effective against Delta COVID-19 variants-study

* Variants may cause few breakthrough infections in vaccinated* Researchers find no evidence of widespread virus escape* Past infection with B117/Alpha confers broad protection (Recasts, adds details on Pfizer-BioNTech vaccine)By Ludwig Burger and ...

22 Jun 21 19:53

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.